I will say this again and repeat why I was bearish on PFE stk during the Delta/Omicron waves in 2021 - NOBODY, not even God, can beat the multiple compression in a pharma stk when the topline stops growing - and in fact it was going in reverse (shrinking) in 2023 - what happen these variants are the best free "vax" from natural and covid goes away... I don't blame Bourla for not able to manage the sudden collapse in covid biz - I do blame him and his BD team for all those deal debacles - .. they thought they have an endless fire hydrant of cash flow to do deals - and not thinking about the value of what they chase -.(screw those consultant decks from McK and others - ALL garbage).. . they didn't learn from the experience w/ 2019 ARRY case w/ bidding against itself and got played - .. why rush into assets with either proven weak in the same class for commercial sales or assets w/ incomplete data information for the ultimate success - .. missing a billion here, a billion there hurts - missing 10B here, 7B there, 5B again - just catastrophic - these things add up.. they better not F-up w/. the SGEN case - .. more changes (on top of what's going on now) - imo, increases the odds they will F-up w/ SGEN integration.